Type 2 Cardiorenal Syndrome으로 투석을 시행한 환자의 특징과 생존율

• Published in: Kidney research and clinical practice Vol. 30; no. 6; pp. 614 - 621
• Main Authors: 조성, Seong Cho, 김성록, Sung Rok Kim, 이유지, Yu Ji Lee
• Format: Journal Article
• Language: Korean
• Published: 대한신장학회 30.11.2011
• Subjects: Dialysis; Hospitalization; Type 2 cardiorenal syndrome; 내과학
• ISSN: 2211-9132; 2211-9140

Purpose: We evaluated clinical outcomes in patients with type 2 cardiorenal syndrome who were treated with peritoneal dialysis (PD) or hemodialysis (HD). Methods: A retrospective database of PD or HD patients with type 2 cardiorenal syndrome from January 2002 to December 32010 was established. We evaluated the mean survival on dialysis, days of hospitalizations and NYHA class changes. Results: Thirty-two patients with mean age at the start of dialysis of 68.4±10.8 years had mean survival on dialysis of 20.5±14.4 months (median survival 17.8 months). Survival after starting dialysis is highly variable, but long term survival was proved possible. The days of hospitalization for cardiovascular causes were reduced (25.1±17.predialysis vs. 9.5±32.8 days/patient/month, postdialysis, p= 0.013). All patients showed improvement in NYHA functional class. Kidney function stabilized, while significant improvement in hemoglobin (+16.5%, p<0.001) were achieved. Conclusion: After starting dialysis for Type 2 cardiorenal syndrome, the chances of hospitalization for cardiovascular causes were reduced for all patients. Survival on dialysis in these patients was highly variable.